Non‐alcoholic fatty liver disease (NAFLD) comprises a wide spectrum of pathologies
ranging from non‐alcoholic fatty liver (NAFL), characterized by simple steatosis without …

Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …

This is the first American Association for the Study of Liver Diseases (AASLD) practice
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …

Background & Aims The Model for End-Stage Liver Disease (MELD) has been established
as a reliable indicator of short-term survival in patients with end-stage liver disease. The …

For several decades, understanding ageing and the processes that limit lifespan have
challenged biologists. Thirty years ago, the biology of ageing gained unprecedented …

Liver cirrhosis is an increasing public health threat worldwide. Malnutrition is a serious
complication of cirrhosis and is associated with worse outcomes. With this review, we aim to …

Abstract Background and Aims In patients with NAFLD, those with type 2 diabetes mellitus
(DM) have a high risk of progression to HCC. However, the determinants of HCC risk in …

Background: End-stage liver disease is a common cause of morbidity and mortality
worldwide, yet little is known about its symptomatology and impact on health-related quality …

Background Malnutrition/sarcopenia and frailty are common in patients with cirrhosis and
are associated with poor outcomes. Aim To provide an overview of data on the importance …

A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored
by the American Society of Transplantation (AST) and endorsed by the American Society of …